A Safety and Efficacy Study of Ispronicline (TC-1734-112) in Subjects With Age Associated Memory Impairment (AAMI)

NCT00109564 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

174

Enrollment

INDUSTRY

Sponsor class

Conditions

Age-Related Memory Disorders

Interventions

DRUG: ispronicline (nicotinic acetylcholine receptor agonist)

Sponsor

Targacept Inc.